OCUL Insider Trading

Insider Ownership Percentage: 5.50%
Insider Buying (Last 12 Months): $24,765.00
Insider Selling (Last 12 Months): $165,878.96

Ocular Therapeutix Insider Trading History Chart

This chart shows the insider buying and selling history at Ocular Therapeutix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ocular Therapeutix Share Price & Price History

Current Price: $2.29
Price Change: Price Increase of +0.06 (2.69%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for OCUL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ocular Therapeutix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2023Antony C. MattessichCEOBuy6,500$3.81$24,765.006,500View SEC Filing Icon  
7/7/2023Rabia Gurses OzdenInsiderSell832$4.93$4,101.76100,531View SEC Filing Icon  
2/6/2023Antony C. MattessichCEOSell19,669$4.24$83,396.56446,281View SEC Filing Icon  
2/6/2023Christopher G WhiteInsiderSell5,829$4.24$24,714.9694,766View SEC Filing Icon  
2/6/2023Donald NotmanCFOSell6,476$4.24$27,458.24139,387View SEC Filing Icon  
2/6/2023Philip C StrassburgerGeneral CounselSell6,181$4.24$26,207.44109,071View SEC Filing Icon  
11/7/2022Summer Road LlcMajor ShareholderBuy7,328$3.50$25,648.006,122,089View SEC Filing Icon  
10/10/2022Summer Road LlcMajor ShareholderBuy10,000$4.00$40,000.006,104,761View SEC Filing Icon  
9/29/2022Summer Road LlcMajor ShareholderBuy18,800$4.04$75,952.006,094,761View SEC Filing Icon  
9/27/2022Summer Road LlcMajor ShareholderBuy130,000$4.68$608,400.006,074,761View SEC Filing Icon  
2/23/2022Summer Road LlcMajor ShareholderBuy10,000$4.80$48,000.00View SEC Filing Icon  
2/18/2022Summer Road LlcMajor ShareholderBuy40,000$5.00$200,000.00View SEC Filing Icon  
1/27/2022Summer Road LlcMajor ShareholderBuy1,477$5.20$7,680.40View SEC Filing Icon  
1/24/2022Summer Road LlcMajor ShareholderBuy44,400$5.31$235,764.00View SEC Filing Icon  
1/20/2022Summer Road LlcMajor ShareholderBuy17,948$5.70$102,303.60View SEC Filing Icon  
1/18/2022Summer Road LlcMajor ShareholderBuy6,807$6.00$40,842.00View SEC Filing Icon  
1/13/2022Summer Road LlcMajor ShareholderBuy10,000$6.20$62,000.00View SEC Filing Icon  
12/15/2021Summer Road LlcMajor ShareholderBuy15,000$6.22$93,300.00View SEC Filing Icon  
12/13/2021Summer Road LlcMajor ShareholderBuy10,510$6.50$68,315.00View SEC Filing Icon  
12/10/2021Summer Road LlcMajor ShareholderBuy30,000$6.65$199,500.00View SEC Filing Icon  
12/8/2021Summer Road LlcMajor ShareholderBuy5,300$6.75$35,775.00View SEC Filing Icon  
12/6/2021Summer Road LlcMajor ShareholderBuy55,600$6.13$340,828.00View SEC Filing Icon  
8/20/2021Antony C. MattessichCEOBuy5,000$9.89$49,450.00102,900View SEC Filing Icon  
5/20/2021Richard L. LindstromDirectorSell10,000$14.30$143,000.0090,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

54.42% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OCUL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ocular Therapeutix Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/24/2023Deutsche Bank AG35,806$0.11M0.0%+20.0%0.045%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.95,363$0.30M0.0%N/A0.120%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al174,167$0.55M0.0%-13.3%0.219%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP233,582$0.73M0.1%+96.4%0.294%Search for SEC Filing on Google Icon
11/15/2023Royal Bank of Canada169,772$0.53M0.0%+2.9%0.214%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.969,350$3.04M0.6%+20.8%1.221%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC67,204$0.21M0.0%+59.1%0.085%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System17,220$54K0.0%-33.7%0.022%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC20,827$65K0.0%+94.1%0.026%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC25,480$80K0.0%-48.2%0.032%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp673,736$2.12M0.0%+1.7%0.848%Search for SEC Filing on Google Icon
11/13/2023Paradigm Capital Management Inc. NY80,000$0.25M0.0%+100.0%0.101%Search for SEC Filing on Google Icon
11/13/2023Invesco Ltd.249,939$0.79M0.0%+40.0%0.315%Search for SEC Filing on Google Icon
11/13/2023FMR LLC68,780$0.22M0.0%+1,048.8%0.087%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC11,837$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers130,016$0.41M0.0%+6.4%0.164%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG35,806$0.11M0.0%+20.0%0.045%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.20,132$63K0.0%-44.3%0.025%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG53,574$0.17M0.0%-58.8%0.067%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund31,521$99K0.0%+229.0%0.040%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC25,963$81K0.0%+22.9%0.033%Search for SEC Filing on Google Icon
10/31/2023Levin Capital Strategies L.P.22,500$71K0.0%-30.8%0.028%Search for SEC Filing on Google Icon
10/26/2023Emerald Advisers LLC20,768$65K0.0%-54.6%0.026%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp240,310$0.76M0.0%-18.1%0.303%Search for SEC Filing on Google Icon
10/24/2023Raymond James Financial Services Advisors Inc.74,401$0.23M0.0%+46.6%0.094%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates120,561$0.38M0.0%+155.2%0.152%Search for SEC Filing on Google Icon
10/23/2023Deltec Asset Management LLC2,061,797$6.47M1.5%+4.4%2.597%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC12,242$38K0.0%N/A0.015%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC21,123$0.11M0.0%-92.4%0.027%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System25,960$0.13M0.0%-9.4%0.033%Search for SEC Filing on Google Icon
8/18/2023Legato Capital Management LLC116,389$0.60M0.1%N/A0.147%Search for SEC Filing on Google Icon
8/17/2023Coastal Bridge Advisors LLC10,900$56K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.88,600$0.46M0.0%-5.2%0.112%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN34,513$0.18M0.0%+94.0%0.043%Search for SEC Filing on Google Icon
8/15/2023Walleye Capital LLC43,665$0.23M0.0%+132.1%0.055%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.207,492$1.07M0.0%+14.8%0.261%Search for SEC Filing on Google Icon
8/15/2023Royal Bank of Canada165,055$0.85M0.0%-10.4%0.208%Search for SEC Filing on Google Icon
8/15/2023Boothbay Fund Management LLC17,880$92K0.0%-50.0%0.023%Search for SEC Filing on Google Icon
8/15/2023Banco Santander S.A.397,443$2.05M0.0%+48.4%0.501%Search for SEC Filing on Google Icon
8/15/2023Bayesian Capital Management LP37,400$0.19M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/14/2023Cormorant Asset Management LP645,000$3.33M0.2%N/A0.812%Search for SEC Filing on Google Icon
8/14/2023Tudor Investment Corp Et Al200,843$1.04M0.0%+193.7%0.253%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP15,149$78K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2023State Street Corp1,576,213$8.13M0.0%+5.6%1.985%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC919,602$4.75M0.0%+376.4%1.158%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC24,893$0.13M0.0%-65.0%0.031%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.5,262,920$27.16M0.0%+7.0%6.629%Search for SEC Filing on Google Icon
8/11/2023Harvest Investment Services LLC61,960$0.32M0.2%N/A0.078%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.802,680$4.14M0.7%N/A1.011%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC1,569,904$8.10M0.0%+7.7%1.977%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp662,510$3.42M0.0%+0.8%0.835%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC10,728$55K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.214,415$1.11M0.0%+4.0%0.277%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.36,145$0.19M0.0%+96.2%0.047%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC20,174$0.10M0.0%-58.2%0.026%Search for SEC Filing on Google Icon
8/8/2023Rhumbline Advisers122,223$0.63M0.0%+13.3%0.158%Search for SEC Filing on Google Icon
8/7/2023Lincoln National Corp57,226$0.30M0.0%N/A0.074%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC21,123$0.11M0.0%-92.4%0.027%Search for SEC Filing on Google Icon
8/3/2023Mackenzie Financial Corp44,173$0.22M0.0%-33.0%0.057%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp293,412$1.51M0.0%+1.2%0.378%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can181,509$0.94M0.0%N/A0.234%Search for SEC Filing on Google Icon
7/31/2023Levin Capital Strategies L.P.32,500$0.17M0.0%-84.3%0.042%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio38,200$0.20M0.0%-34.0%0.049%Search for SEC Filing on Google Icon
7/28/2023Carson Advisory Inc.11,852$0.70M0.4%N/A0.015%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC13,383$69K0.0%N/A0.017%Search for SEC Filing on Google Icon
7/27/2023Carson Advisory Inc.11,852$0.70M0.6%N/A0.015%Search for SEC Filing on Google Icon
7/25/2023Raymond James Financial Services Advisors Inc.50,764$0.26M0.0%+244.0%0.065%Search for SEC Filing on Google Icon
7/25/2023DekaBank Deutsche Girozentrale100,000$0.51M0.0%+300.0%0.129%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC15,803$82K0.0%+366.2%0.020%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.10,000$52K0.0%-60.0%0.013%Search for SEC Filing on Google Icon
7/19/2023Daymark Wealth Partners LLC25,000$0.13M0.0%N/A0.032%Search for SEC Filing on Google Icon
7/18/2023Deltec Asset Management LLC1,974,797$10.19M2.2%+3.2%2.547%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC15,803$82K0.0%+366.2%0.020%Search for SEC Filing on Google Icon
5/26/2023ProShare Advisors LLC14,408$76K0.0%-11.5%0.019%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.35,420$0.19M0.0%+16.5%0.046%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.63,941$0.34M0.0%+38.7%0.082%Search for SEC Filing on Google Icon
5/18/2023New York State Common Retirement Fund31,453$0.17M0.0%-41.1%0.041%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC117,046$0.62M0.0%+323.7%0.151%Search for SEC Filing on Google Icon
5/16/2023State Street Corp1,492,959$7.87M0.0%+7.6%1.926%Search for SEC Filing on Google Icon
5/16/2023Steward Partners Investment Advisory LLC6,000$32K0.0%-35.0%0.008%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC1,457,740$7.68M0.0%+3.3%1.880%Search for SEC Filing on Google Icon
5/16/2023Graham Capital Management L.P.77,661$0.41M0.0%N/A0.100%Search for SEC Filing on Google Icon
5/16/2023AQR Capital Management LLC42,518$0.22M0.0%-62.2%0.055%Search for SEC Filing on Google Icon
5/16/2023Balyasny Asset Management L.P.16,114$85K0.0%-35.5%0.021%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC42,989$0.23M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP309,400$1.63M0.0%-3.8%0.399%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP323,424$1.70M0.0%+71.0%0.417%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG51,075$0.27M0.0%+46.4%0.066%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD38,295$0.20M0.0%-8.5%0.049%Search for SEC Filing on Google Icon
5/15/2023Cetera Investment Advisers601,150$3.17M0.0%+1.0%0.775%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC71,193$0.38M0.0%-75.8%0.092%Search for SEC Filing on Google Icon
5/12/2023Aristides Capital LLC35,000$0.18M0.1%N/A0.045%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.4,918,309$25.92M0.0%-0.7%6.345%Search for SEC Filing on Google Icon
5/12/2023BNP Paribas Arbitrage SNC48,231$0.25M0.0%+199.0%0.062%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE66,781$0.35M0.0%-31.9%0.086%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP24,319$0.13M0.0%-89.6%0.031%Search for SEC Filing on Google Icon
5/12/2023Wellington Management Group LLP307,108$1.62M0.0%-1.9%0.396%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd72,457$0.38M0.2%-29.3%0.093%Search for SEC Filing on Google Icon
5/12/2023ProShare Advisors LLC14,408$76K0.0%-11.5%0.019%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.206,249$1.09M0.0%+0.8%0.266%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ocular Therapeutix logo
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. Ocular Therapeutix, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). The company was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Read More on Ocular Therapeutix

Today's Range

Now: $2.29
Low: $2.16
High: $2.30

50 Day Range

MA: $2.64
Low: $2.08
High: $3.40

52 Week Range

Now: $2.29
Low: $2.00
High: $7.96

Volume

363,846 shs

Average Volume

1,121,642 shs

Market Capitalization

$181.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Ocular Therapeutix?

Ocular Therapeutix's top insider investors include:
  1. Summer Road Llc (Major Shareholder)
  2. Antony C Mattessich (CEO)
  3. Donald Notman (CFO)
  4. Philip C Strassburger (General Counsel)
  5. Rabia Gurses Ozden (Insider)
  6. Christopher G White (Insider)
Learn More about top insider investors at Ocular Therapeutix.

Who are the major institutional investors of Ocular Therapeutix?

Ocular Therapeutix's top institutional investors include:
  1. Deltec Asset Management LLC — 2.60%
  2. Sectoral Asset Management Inc. — 1.22%
  3. Northern Trust Corp — 0.85%
  4. Invesco Ltd. — 0.31%
  5. Bank of New York Mellon Corp — 0.30%
  6. GSA Capital Partners LLP — 0.29%
Learn More about top institutional investors of Ocular Therapeutix stock.

Which major investors are selling Ocular Therapeutix stock?

In the previous quarter, OCUL stock was sold by these institutional investors:
  1. UBS Group AG
  2. Bank of New York Mellon Corp
  3. Tudor Investment Corp Et Al
  4. Emerald Advisers LLC
  5. Algert Global LLC
  6. Citigroup Inc.
  7. Levin Capital Strategies L.P.
  8. California State Teachers Retirement System
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
  1. Summer Road Llc (Major Shareholder)
  2. Antony C Mattessich (CEO)
  3. Donald Notman (CFO)
  4. Philip C Strassburger (General Counsel)
  5. Rabia Gurses Ozden (Insider)
Learn More investors selling Ocular Therapeutix stock.

Which major investors are buying Ocular Therapeutix stock?

During the previous quarter, OCUL stock was acquired by institutional investors including:
  1. Sectoral Asset Management Inc.
  2. GSA Capital Partners LLP
  3. Graham Capital Management L.P.
  4. Deltec Asset Management LLC
  5. Raymond James & Associates
  6. Invesco Ltd.
  7. FMR LLC
  8. Paradigm Capital Management Inc. NY
During the previous year, these company insiders have bought Ocular Therapeutix stock:
  1. Summer Road Llc (Major Shareholder)
  2. Antony C Mattessich (CEO)
Learn More investors buying Ocular Therapeutix stock.